Torsten Tonn

Retargeting of natural killer-cell cytolytic activity to ErbB2-expressing cancer cells results in efficient and selective tumor cell destruction.

Sven Becker, W. Wels, C. Uherek, 2002, Blood.

Standardization of Good Manufacturing Practice-compliant production of bone marrow-derived human mesenchymal stromal cells for immunotherapeutic applications.

Wolfgang Wagner, Ingo Müller, Martin Bornhäuser, 2015, Cytotherapy.

Selection and expansion of natural killer cells for NK cell-based immunotherapy

Peter Bader, E. Seifried, T. Tonn, 2016, Cancer Immunology, Immunotherapy.

Protein scaffold and expression level determine antiviral activity of membrane-anchored antiviral peptides.

Christopher Baum, Ursula Dietrich, U. Dietrich, 2008, Human gene therapy.

Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paper

Andrew F. Hill, Bernd Giebel, André Görgens, 2015, Journal of extracellular vesicles.